News Focus
News Focus
Followers 44
Posts 287
Boards Moderated 0
Alias Born 05/06/2022

Re: exwannabe post# 740271

Sunday, 01/05/2025 5:33:56 PM

Sunday, January 05, 2025 5:33:56 PM

Post# of 823596
Why do you think I said 'in it's forthcoming combination forms'?

Because in it's forthcoming combinations with Poly-ICLC alone it will render the existing SOC completely redundant. The only thing that will remain from the existing SOC will be the resection and I am willing to bet that by 2028-2030 DCVax-Direct will be replacing at least some resections for less complicated/ early onset GBMs and Gliomas.

Now add in forthcoming (2027-8) off-label (cheap) PD-1 inhibitors and CSFR-1 inhibitors like PLX3397 (Pexidartinib) and you have a treatment that - end-to-end - is still going to be considerably cheaper for anyone involved in footing the bill, not to mention orders of magnitude more efficacious!

If I were a patient with the choice of being fried by radiation & poisoned by chemo or being given a immunotherapeutic cocktail of my own supercharged cells back to me with a vastly lower toxicity profile, a considerably better expected QOL, and much higher chance of survival I would knock down every fuckin door in sight to get the latter! Patient advocacy groups will be doing exactly that!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News